Author: Frédérique Bawin
Publisher: Gompel&Svacina
ISBN: 9463713417
Category : Self-Help
Languages : en
Pages : 234
Book Description
The growing use of prescription drugs is a global health concern. A “pill-popping culture”, where many life issues are seen as problems that can be treated with medication, is becoming more common worldwide. Simultaneously, there are increasing concerns about the nonmedical use of prescription drugs (NMUPD) such as sedatives, opi-oid-based pain relief medication and prescription stimu-lants. Nevertheless, this trend has received limited atten-tion in scientific research in Belgium, and in Europe more broadly. The YOUTH-PUMED study described in this book aims at a better understanding of this phenomenon among young adults, and of their perceptions about their own nonmedical use of prescription drugs and associated harms. This book shows that the young adults were using one or more psychoactive medication (sedatives, analgesics or stimulants) in different contexts, and their use patterns and motives for use varied. It ends with helpful insights to prevent and reduce NMUPD.
Young adults using prescription drugs nonmedically
Author: Frédérique Bawin
Publisher: Gompel&Svacina
ISBN: 9463713417
Category : Self-Help
Languages : en
Pages : 234
Book Description
The growing use of prescription drugs is a global health concern. A “pill-popping culture”, where many life issues are seen as problems that can be treated with medication, is becoming more common worldwide. Simultaneously, there are increasing concerns about the nonmedical use of prescription drugs (NMUPD) such as sedatives, opi-oid-based pain relief medication and prescription stimu-lants. Nevertheless, this trend has received limited atten-tion in scientific research in Belgium, and in Europe more broadly. The YOUTH-PUMED study described in this book aims at a better understanding of this phenomenon among young adults, and of their perceptions about their own nonmedical use of prescription drugs and associated harms. This book shows that the young adults were using one or more psychoactive medication (sedatives, analgesics or stimulants) in different contexts, and their use patterns and motives for use varied. It ends with helpful insights to prevent and reduce NMUPD.
Publisher: Gompel&Svacina
ISBN: 9463713417
Category : Self-Help
Languages : en
Pages : 234
Book Description
The growing use of prescription drugs is a global health concern. A “pill-popping culture”, where many life issues are seen as problems that can be treated with medication, is becoming more common worldwide. Simultaneously, there are increasing concerns about the nonmedical use of prescription drugs (NMUPD) such as sedatives, opi-oid-based pain relief medication and prescription stimu-lants. Nevertheless, this trend has received limited atten-tion in scientific research in Belgium, and in Europe more broadly. The YOUTH-PUMED study described in this book aims at a better understanding of this phenomenon among young adults, and of their perceptions about their own nonmedical use of prescription drugs and associated harms. This book shows that the young adults were using one or more psychoactive medication (sedatives, analgesics or stimulants) in different contexts, and their use patterns and motives for use varied. It ends with helpful insights to prevent and reduce NMUPD.
National Survey on Drug Abuse
Author:
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 170
Book Description
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 170
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Medications for Opioid Use Disorder Save Lives
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Monitoring the Future, National Survey Results on Drug Use
Author:
Publisher:
ISBN:
Category : College students
Languages : en
Pages : 744
Book Description
Publisher:
ISBN:
Category : College students
Languages : en
Pages : 744
Book Description
Massachusetts General Hospital Psychopharmacology
Author: Theodore A. Stern
Publisher: Elsevier
ISBN: 9780323357654
Category : Medical
Languages : en
Pages : 224
Book Description
Publisher: Elsevier
ISBN: 9780323357654
Category : Medical
Languages : en
Pages : 224
Book Description
Relieving Pain in America
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 030921484X
Category : Medical
Languages : en
Pages : 383
Book Description
Chronic pain costs the nation up to $635 billion each year in medical treatment and lost productivity. The 2010 Patient Protection and Affordable Care Act required the Department of Health and Human Services (HHS) to enlist the Institute of Medicine (IOM) in examining pain as a public health problem. In this report, the IOM offers a blueprint for action in transforming prevention, care, education, and research, with the goal of providing relief for people with pain in America. To reach the vast multitude of people with various types of pain, the nation must adopt a population-level prevention and management strategy. The IOM recommends that HHS develop a comprehensive plan with specific goals, actions, and timeframes. Better data are needed to help shape efforts, especially on the groups of people currently underdiagnosed and undertreated, and the IOM encourages federal and state agencies and private organizations to accelerate the collection of data on pain incidence, prevalence, and treatments. Because pain varies from patient to patient, healthcare providers should increasingly aim at tailoring pain care to each person's experience, and self-management of pain should be promoted. In addition, because there are major gaps in knowledge about pain across health care and society alike, the IOM recommends that federal agencies and other stakeholders redesign education programs to bridge these gaps. Pain is a major driver for visits to physicians, a major reason for taking medications, a major cause of disability, and a key factor in quality of life and productivity. Given the burden of pain in human lives, dollars, and social consequences, relieving pain should be a national priority.
Publisher: National Academies Press
ISBN: 030921484X
Category : Medical
Languages : en
Pages : 383
Book Description
Chronic pain costs the nation up to $635 billion each year in medical treatment and lost productivity. The 2010 Patient Protection and Affordable Care Act required the Department of Health and Human Services (HHS) to enlist the Institute of Medicine (IOM) in examining pain as a public health problem. In this report, the IOM offers a blueprint for action in transforming prevention, care, education, and research, with the goal of providing relief for people with pain in America. To reach the vast multitude of people with various types of pain, the nation must adopt a population-level prevention and management strategy. The IOM recommends that HHS develop a comprehensive plan with specific goals, actions, and timeframes. Better data are needed to help shape efforts, especially on the groups of people currently underdiagnosed and undertreated, and the IOM encourages federal and state agencies and private organizations to accelerate the collection of data on pain incidence, prevalence, and treatments. Because pain varies from patient to patient, healthcare providers should increasingly aim at tailoring pain care to each person's experience, and self-management of pain should be promoted. In addition, because there are major gaps in knowledge about pain across health care and society alike, the IOM recommends that federal agencies and other stakeholders redesign education programs to bridge these gaps. Pain is a major driver for visits to physicians, a major reason for taking medications, a major cause of disability, and a key factor in quality of life and productivity. Given the burden of pain in human lives, dollars, and social consequences, relieving pain should be a national priority.
Results from the ... National Survey on Drug Use and Health
Author: National Survey on Drug Use and Health (U.S.)
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 288
Book Description
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 288
Book Description
Drug Policy and the Public Good
Author: Thomas Babor
Publisher: Oxford University Press
ISBN: 0192550276
Category : Medical
Languages : en
Pages : 349
Book Description
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
Publisher: Oxford University Press
ISBN: 0192550276
Category : Medical
Languages : en
Pages : 349
Book Description
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
Monitoring the Future: National Survey Results on Drug Use, 1975-2008: Volume II
Author: Lloyd D. Johnston
Publisher: DIANE Publishing
ISBN: 1437926355
Category : Education
Languages : en
Pages : 329
Book Description
Contents: Chapter 1: Introduction; Chapter 2: Key Findings: An Overview and Integration Across Five Populations; Chapter 3: Study Design and Procedures; Chapter 4: Prevalence of Drug Use in Early and Middle Adulthood; Chapter 5: Trends in Drug Use in Early and Middle Adulthood; Chapter 6: Attitudes and Beliefs about Drugs Among Young Adults; Chapter 7: The Social Context; Chapter 8: Prevalence of Drug Use Among College Students; Chapter 9: Trends in Drug Use Among College Students. Charts and tables.
Publisher: DIANE Publishing
ISBN: 1437926355
Category : Education
Languages : en
Pages : 329
Book Description
Contents: Chapter 1: Introduction; Chapter 2: Key Findings: An Overview and Integration Across Five Populations; Chapter 3: Study Design and Procedures; Chapter 4: Prevalence of Drug Use in Early and Middle Adulthood; Chapter 5: Trends in Drug Use in Early and Middle Adulthood; Chapter 6: Attitudes and Beliefs about Drugs Among Young Adults; Chapter 7: The Social Context; Chapter 8: Prevalence of Drug Use Among College Students; Chapter 9: Trends in Drug Use Among College Students. Charts and tables.